Angioplasty Procedure
Angioplasty Procedure - Related Videos
06:59
Catheter-based Endovascular Angioplasty for Fibrosing Mediastinitis-associated Pulmonary Vein Stenosis
0 Views •
2025
Pulmonary vein stenosis (PVS) is a life-threatening complication of fibrosing mediastinitis (FM), with a poor prognosis if not properly treated. Currently, catheter-based endovascular angioplasty is a promising therapeutic strategy for FM-associated PVS. This protocol primarily outlines a stepwise approach to the transcatheter procedure for FM-associated PVS.
06:04
Patch Angioplasty in the Rat Aorta or Inferior Vena Cava
0 Views •
Cited by 16 •
2017
We have established a model of pericardial patch angioplasty that can be used in either small-diameter veins or arteries. This model can be used to compare venous and arterial neointimal hyperplasia formation.
10:03
Coronary Progenitor Cells and Soluble Biomarkers in Cardiovascular Prognosis after Coronary Angioplasty
0 Views •
Cited by 2 •
2020
Development of major adverse cardiovascular events, which impact cardiovascular prognosis after coronary angioplasty, are influenced by the extent of coronary damage and vascular repair. The use of novel coronary cellular and soluble biomarkers, reactive to vascular damage and repair, are useful to predict the development of MACEs and prognosis.
02:07
Blind Procedures
0 Views •
2020
Ideally, the people who observe and record the children’s behavior are unaware of who was assigned to the experimental or control group, in order to control for experimenter bias. Experimenter bias refers to the possibility that a researcher’s expectations might skew the results of the study. Remember, conducting an experiment requires a lot of planning, and the people involved in the research project have a vested interest in supporting their hypotheses. If the observers knew which child was...
13:24
Basic Care Procedures
0 Views •
2016
Source: Kay Stewart, RVT, RLATG, CMAR; Valerie A. Schroeder, RVT, RLATG. University of Notre Dame, IN Mice and rats account for a large proportion of the animals used in biomedical research. Ensuring their welfare is both an ethical responsibility and essential for scientific validity. There are general procedures that apply to the majority of these mice and rats, but some of the animals, such as the immunocompromised ones, require additional steps to be taken to sustain them for...
FAQs
Balloon inflation mechanically compresses plaque against the arterial wall, enlarging the passage available for blood flow. The procedure therefore acts directly on the physical obstruction rather than only managing its consequences pharmacologically. In cardiovascular care, that mechanical change can improve circulation through a narrowed or blocked coronary artery and help relieve ischemic symptoms.
A stent provides structural support after balloon treatment, helping the vessel remain open and maintain patency. A drug-eluting device adds a local pharmacological action: it releases medication at the treated site to limit tissue regrowth. This combines mechanical support with site-specific drug delivery, addressing both vessel openness and a biological response that could reduce it.
Antiplatelet therapy is used after angioplasty to help prevent clot formation. Its role differs from balloon inflation, which changes the narrowed vessel mechanically, and from drug-eluting devices, which release medication locally to limit tissue regrowth. This pharmacological component therefore addresses a clot-related threat to the treated vessel during post-procedure management.
During the angioplasty procedure, clinicians guide a catheter through the vascular system until it reaches the obstruction. They then inflate a small balloon to compress plaque against the arterial wall. A stent may be placed afterward to help maintain patency, with drug-eluting devices providing medication locally when used.
Angioplasty is especially relevant when impaired arterial circulation produces ischemic symptoms, and the coronary arteries are its most common treatment location. By restoring flow through the affected vessel, the intervention can relieve those symptoms and reduce complications associated with impaired circulation. This makes it an important intersection of cardiovascular intervention and pharmacological aftercare.
Pharmacology contributes at two points: drug-eluting devices release medication locally at the treated vessel, while antiplatelet therapy helps prevent clot formation afterward. These approaches do not replace the catheter and balloon's mechanical work. Instead, they complement it by addressing tissue regrowth at the treatment site and clot-related risk following the intervention.